Hamm CW - Search Results

1

Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy.

Nef HM, Möllmann H, Hilpert P, Troidl C, Voss S, Rolf A, Behrens CB, Weber M, Hamm CW, Elsässer A. Nef HM, et al. Among authors: hamm cw. Eur J Heart Fail. 2009 Aug;11(8):758-64. doi: 10.1093/eurjhf/hfp076. Eur J Heart Fail. 2009. PMID: 19633102 Free article.

2

Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death.

Elsässer A, Vogt AM, Nef H, Kostin S, Möllmann H, Skwara W, Bode C, Hamm C, Schaper J. Elsässer A, et al. J Am Coll Cardiol. 2004 Jun 16;43(12):2191-9. doi: 10.1016/j.jacc.2004.02.053. J Am Coll Cardiol. 2004. PMID: 15193679 Free article.

3

Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.

Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C. Weber M, et al. Am J Cardiol. 2004 Sep 15;94(6):740-5. doi: 10.1016/j.amjcard.2004.05.055. Am J Cardiol. 2004. PMID: 15374777

4

N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic V, Hamm C. Weber M, et al. Am Heart J. 2004 Oct;148(4):612-20. doi: 10.1016/j.ahj.2004.04.021. Am Heart J. 2004. PMID: 15459591 Clinical Trial.

5

Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.

Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Weber M, et al. Eur Heart J. 2005 May;26(10):1023-30. doi: 10.1093/eurheartj/ehi236. Epub 2005 Mar 21. Eur Heart J. 2005. PMID: 15781428

6

Clopidogrel in acute coronary syndrome: when, how much, how long?

Elsässer A, Nef H, Möllmann H, Hamm CW. Elsässer A, et al. Among authors: hamm cw. Z Kardiol. 2005 Jun;94(6):377-82. doi: 10.1007/s00392-005-0224-3. Z Kardiol. 2005. PMID: 15940437 Review.

7

Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.

Weber M, Rau M, Madlener K, Elsaesser A, Bankovic D, Mitrovic V, Hamm C. Weber M, et al. Clin Biochem. 2005 Nov;38(11):1027-30. doi: 10.1016/j.clinbiochem.2005.07.011. Epub 2005 Aug 24. Clin Biochem. 2005. PMID: 16125162

8

Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy.

Brandt RR, Reiner C, Arnold R, Sperzel J, Pitschner HF, Hamm CW. Brandt RR, et al. Among authors: hamm cw. Eur Heart J. 2006 Jan;27(2):187-92. doi: 10.1093/eurheartj/ehi558. Epub 2005 Oct 13. Eur Heart J. 2006. PMID: 16223745

9

[Treatment of ST segment elevation myocardial infarctions according to the guidelines].

Elsässer A, Nef HM, Möllmann H, Hamm CW. Elsässer A, et al. Among authors: hamm cw. Herz. 2005 Dec;30(8):685-94. doi: 10.1007/s00059-005-2769-3. Herz. 2005. PMID: 16331362 Review. German.

10

Primary stenting of the left main coronary artery with anomalous origin from the right sinus of valsalva.

Nef HM, Möllmann H, Möllmann S, Dill T, Hamm CW, Elsässer A. Nef HM, et al. Among authors: hamm cw. Int J Cardiol. 2007 Jan 2;114(1):137-8. doi: 10.1016/j.ijcard.2005.11.049. Epub 2005 Dec 27. Int J Cardiol. 2007. PMID: 16377008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

760 results

Search Page

Filters